相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Epidemiology of the inherited cardiomyopathies
William J. McKenna et al.
NATURE REVIEWS CARDIOLOGY (2021)
Hypertrophic Cardiomyopathy: Genetic Testing and Risk Stratification
Fergus Stafford et al.
CURRENT CARDIOLOGY REPORTS (2021)
A cryptic splice-altering KCNQ1 variant in trans with R259L leading to Jervell and Lange-Nielsen syndrome
Mario Torrado et al.
NPJ GENOMIC MEDICINE (2021)
Transcriptome Sequencing of Patients With Hypertrophic Cardiomyopathy Reveals Novel Splice-Altering Variants in MYBPC3
Mira Holliday et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2021)
Benchmarking deep learning splice prediction tools using functional splice assays
Tabea V. Riepe et al.
HUMAN MUTATION (2021)
Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy
Carmen Suay-Corredera et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Role of Splicing Regulatory Elements and In Silico Tools Usage in the Identification of Deep Intronic Splicing Variants in Hereditary Breast/Ovarian Cancer Genes
Alejandro Moles-Fernandez et al.
CANCERS (2021)
Pathogenic Intronic Splice-Affecting Variants in MYBPC3 in Three Patients with Hypertrophic Cardiomyopathy
Katherine A. Wood et al.
CARDIOGENETICS (2021)
Whole MYBPC3 NGS sequencing as a molecular strategy to improve the efficiency of molecular diagnosis of patients with hypertrophic cardiomyopathy
Alexandre Janin et al.
HUMAN MUTATION (2020)
RNA Splicing by the Spliceosome
Max E. Wilkinson et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 89 (2020)
Assessment of branch point prediction tools to predict physiological branch points and their alteration by variants
Raphael Leman et al.
BMC GENOMICS (2020)
Blood RNA analysis can increase clinical diagnostic rate and resolve variants of uncertain significance
Htoo A. Wai et al.
GENETICS IN MEDICINE (2020)
AG-exclusion zone revisited: Lessons to learn from 91 intronic NF1 3′ splice site mutations outside the canonical AG-dinucleotides
Katharina Wimmer et al.
HUMAN MUTATION (2020)
Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing?
Francesco Mazzarotto et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Cryptic Splice-Altering Variants in MYBPC3 Are a Prevalent Cause of Hypertrophic Cardiomyopathy
Luis R. Lopes et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2020)
Reevaluation of the South AsianMYBPC3Δ25bpIntronic Deletion in Hypertrophic Cardiomyopathy
Andrew R. Harper et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2020)
Predicting Splicing from Primary Sequence with Deep Learning
Kishore Jaganathan et al.
CELL (2019)
Key Value of RNA Analysis of MYBPC3 Splice-Site Variants in Hypertrophic Cardiomyopathy
Emma S. Singer et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2019)
Branch Point Selection in RNA Splicing Using Deep Learning
Iman Nazari et al.
IEEE ACCESS (2019)
Most human introns are recognized via multiple and tissue-specific branchpoints
Jose Mario Bello Pineda et al.
GENES & DEVELOPMENT (2018)
Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen's Inherited Cardiomyopathy Expert Panel
Melissa A. Kelly et al.
GENETICS IN MEDICINE (2018)
Whole Genome Sequencing Improves Outcomes of Genetic Testing in Patients With Hypertrophic Cardiomyopathy
Richard D. Bagnall et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
A sequence-based, deep learning model accurately predicts RNA splicing branchpoints
Joseph M. Paggi et al.
RNA (2018)
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)
Carolyn Y. Ho et al.
CIRCULATION (2018)
Machine learning annotation of human branchpoints
Bethany Signal et al.
BIOINFORMATICS (2018)
Identification of pathogenic gene mutations in LMNA and MYBPC3 that alter RNA splicing
Kaoru Ito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
BPP: a sequence-based algorithm for branch point prediction
Qing Zhang et al.
BIOINFORMATICS (2017)
Hypertrophic Cardiomyopathy Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy
Ali J. Marian et al.
CIRCULATION RESEARCH (2017)
Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)-Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy
Adaya Weissler-Snir et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2017)
Functional Studies and In Silico Analyses to Evaluate Non-Coding Variants in Inherited Cardiomyopathies
Giulia Frisso et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Functional Characterization of Putative Novel Splicing Mutations in the Cardiomyopathy-Causing Genes
Gilles Millat et al.
DNA AND CELL BIOLOGY (2015)
Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity
Ahmed A. Alfares et al.
GENETICS IN MEDICINE (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Genome-wide discovery of human splicing branchpoints
Tim R. Mercer et al.
GENOME RESEARCH (2015)
New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy
Christopher Semsarian et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Compound heterozygous or homozygous truncating MYBPC3 mutations cause lethal cardiomyopathy with features of noncompaction and septal defects
Marja W. Wessels et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2015)
Sarcomere Mutation-Specific Expression Patterns in Human Hypertrophic Cardiomyopathy
Adam S. Helms et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2014)
Myotonic dystrophy: time for evidence-based therapy
Perry Elliott
EUROPEAN HEART JOURNAL (2014)
Hypertrophic cardiomyopathy
Barry J. Maron et al.
LANCET (2013)
Cardiac Myosin Binding Protein-C Mutations in Families With Hypertrophic Cardiomyopathy Disease Expression in Relation to Age, Gender, and Long Term Outcome
Stephen P. Page et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2012)
Combined use of in silico and in vitro splicing assays for interpretation of genomic variants of unknown significance in cardiomyopathies and channelopathies
Herve Crehalet et al.
CARDIOGENETICS (2012)
Clinical Challenges of Genotype Positive (+)-Phenotype Negative (-) Family Members in Hypertrophic Cardiomyopathy
Barry J. Maron et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Two novel mutations of the MYBPC3 gene identified in Chinese families with hypertrophic cardiomyopathy
Jia Lin et al.
CANADIAN JOURNAL OF CARDIOLOGY (2010)
Is genotype clinically useful in predicting prognosis in hypertrophic cardiomyopathy? Mutation Type Is Not Clinically Useful in Predicting Prognosis in Hypertrophic Cardiomyopathy
Andrew P. Landstrom et al.
CIRCULATION (2010)
SpliceAid: a database of experimental RNA target motifs bound by splicing proteins in humans
Francesco Piva et al.
BIOINFORMATICS (2009)
Micro-exons of the cardiac myosin binding protein C gene: flanking introns contain a disproportionately large number of hypertrophic cardiomyopathy mutations
Rune Frank-Hansen et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2008)
Homozygosity for a novel splice site mutation in the cardiac myosin-binding protein c gene causes severe neonatal hypertrophic cardiomyopathy
Baozhong Xin et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2007)
A class of human exons with predicted distant branch points revealed by analysis of AG dinucleotide exclusion zones
C Gooding et al.
GENOME BIOLOGY (2006)
Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland
P Jääskeläinen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2002)
分享论文
